ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-OR022

Staphylococcus Aureus-Induced Tissue Resident Memory T Helper 17 Cells (TRM17 Cells) Drive Renal Autoimmune Disease

Session Information

  • ANCA It Is
    November 09, 2019 | Location: 207, Walter E. Washington Convention Center
    Abstract Time: 04:42 PM - 04:54 PM

Category: Glomerular Diseases

  • 1202 Glomerular Diseases: Immunology and Inflammation

Authors

  • Krebs, Christian F., University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Reimers, Daniel, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Zhao, Yu, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Bartsch, Patricia, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
  • Borchers, Alina, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
  • Hellmig, Malte, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
  • Kilian, Christoph, UKE , Hamburg, Germany
  • Enk, Leon U. B., Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
  • Riedel, Jan-Hendrik, UKE, Hamburg, Germany
  • Huber, Tobias B., University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Turner, Jan-Eric, University Medical Center Hamburg, Hamburg, Germany
  • Panzer, Ulf, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Mittrücker, Hans-willi, Institute for Immunology, Hamburg, Germany
Background

Tissue resident memory T (Trm) cells represent a new type of memory cells that reside in peripheral organs without recirculating. They provide rapid on-site immune protection against previous exposed pathogens. However, it remains to be clarified whether Trm cells also interfere with responses unrelated to the primary infection, such as organ-specific autoimmunity.

Methods

To study Trm cells, we used a combined approach of flow cytometry, histology and single cell RNA-sequencing. Human kidney tissue was obtained from tumour-nephrectomies. In mice, renal Th17 cells were induced by S. aureus infection. GN was induced with the nephrotoxic sheep serum or by immunisation with a fragment of the α3 chain of type IV collagen. We also used Listeria monocytogenes in another infection model.

Results

We found high frequencies of CD4+ CD69+ Trm cells of the Th17 phenotype, which we identified based on homology to published core transcriptional and protein data sets. We operationally named them Trm17 cells. CD4+ Th17 cells are involved in the response to major human pathogens such as S. aureus, and play a critical role in autoimmunity such as crescentic glomerulonephritis (cGN). We established a mouse model of S. aureus infection that resulted in initially high renal bacteria titres and a profound accumulation of Th17 cells in the kidney. Renal Th17 cells persist long-term (>100 days) after clearance of the infection, present with the phenotype of Trm cells and partially protect against re-infection. Induction of autoimmune kidney disease (cGN) in mice, which recovered from S. aureus infection, resulted in a more rapid and aggravated renal Th17 response and consequently developed a more severe course of cGN. By labelling renal cells in photoconvertible Kaede-transgenic mice, we were able to demonstrate that S. aureus induced Trm17 cells contribute significantly to the enhanced local IL-17 immune response in cGN.

Conclusion

Thus, pathogen-induced Trm17 cells in peripheral tissues are capable of rapidly responding to an antigenic unrelated challenge thereby driving renal autoimmune diseases. Our data suggest that Trm cells might have a previously unknown role in amplifying organ-specific autoimmunity.

Funding

  • Government Support - Non-U.S.